Page last updated: 2024-10-31

metronidazole and Toxoplasmosis, Animal

metronidazole has been researched along with Toxoplasmosis, Animal in 2 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegazy, MM1
Elmehankar, MS1
Azab, MS1
El-Tantawy, NL1
Abdel-Aziz, A1
Hagras, NA1
Allam, AF1
Farag, HF1
Osman, MM1
Shalaby, TI1
Fawzy Hussein Mogahed, NM1
Tolba, MM1
Shehab, AY1

Other Studies

2 other studies available for metronidazole and Toxoplasmosis, Animal

ArticleYear
Sex dichotomy in the course of experimental latent toxoplasmosis.
    Experimental parasitology, 2019, Volume: 202

    Topics: Animals; Antibodies, Protozoan; Atovaquone; Brain; Chronic Disease; Coccidiostats; Drug Therapy, Com

2019
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
    Experimental parasitology, 2019, Volume: 204

    Topics: Acute Disease; Animals; Ascitic Fluid; Biocompatible Materials; Blood-Brain Barrier; Brain; Chitosan

2019